BioLineRx Ltd. (TLV:BLRX)
2.200
+0.100 (4.76%)
May 29, 2025, 5:24 PM IDT
BioLineRx Revenue
BioLineRx had revenue of $255.00K USD in the quarter ending March 31, 2025, a decrease of -96.28%. This brings the company's revenue in the last twelve months to $22.34M, up 91.68% year-over-year. In the year 2024, BioLineRx had annual revenue of $28.94M with 502.92% growth.
Revenue (ttm)
$22.34M
Revenue Growth
+91.68%
P/S Ratio
0.59
Revenue / Employee
$797.86K
Employees
28
Market Cap
49.12M ILS
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 61.87B |
Danel (Adir Yeoshua) | 2.81B |
Kamada | 622.70M |
Bait Bakfar | 103.40M |
SofWave Medical | 235.09M |
Novolog (Pharm-Up 1966) | 2.02B |
BrainsWay | 161.81M |
Ilex Medical | 920.37M |
BioLineRx News
- 9 hours ago - Why Is Nano-Cap BioLineRx Stock Surging On Friday? - Benzinga
- 16 hours ago - BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASCO 2025 Annual Meeting - PRNewsWire
- 2 days ago - BioLineRx projects cash runway into H2 2026 while advancing PDAC pipeline and APHEXDA royalty growth - Seeking Alpha
- 3 days ago - BioLineRx Ltd. (BLRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - BioLineRx GAAP EPS of $0.00 beats by $0.95, revenue of $0.26M misses by $1.22M - Seeking Alpha
- 3 days ago - BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 3 days ago - Earnings Scheduled For May 27, 2025 - Benzinga
- 4 days ago - A Look at BioLine Rx's Upcoming Earnings Report - Benzinga